![]() |
|
|
Vol. 30, Issue 2, 208-211, February 2002
Pharmacogenetics Section, Laboratory of Reproductive and
Developmental Toxicology, National Institute of Environmental Health
Sciences, National Institutes of Health, Research Triangle Park, North
Carolina
The nuclear orphan receptor constitutive active receptor (CAR) can
be activated to induce CYP2B genes by the potent
phenobarbital-type inducer 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene
(TCPOBOP) in which the receptor forms a heterodimer with the retinoid X
receptor (RXR) and binds to a conserved enhancer element NR1. Effects
of retinoic acids on the activation of CAR were examined. Treatment with 9-cis- or all-trans-retinoic acid
markedly repressed TCPOBOP induction of CYP2B10 mRNA in mouse primary
hepatocytes. Both retinoic acids also repressed TCPOBOP-induced NR1
enhancer activity in both transfected hepatocytes and HepG2 cells.
Moreover, coexpression of the retinoic acid receptor (RAR) increased
the repression in the cotransfected HepG2 cells, whereas that of RXR
decreased the repression. Thus, the increased heterodimerization of RXR
with RAR by retinoic acid treatment seemed to reduce the RXR available for CAR heterodimerization, resulting in the repression of CAR activity. This type of nuclear receptor signaling may play an important
role as a modulator in the CYP2B regulation.
This article has been cited by other articles:
![]() |
K. Nakamura, R. Moore, M. Negishi, and T. Sueyoshi Nuclear Pregnane X Receptor Cross-talk with FoxA2 to Mediate Drug-induced Regulation of Lipid Metabolism in Fasting Mouse Liver J. Biol. Chem., March 30, 2007; 282(13): 9768 - 9776. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Handschin and U. A. Meyer Induction of Drug Metabolism: The Role of Nuclear Receptors Pharmacol. Rev., December 1, 2003; 55(4): 649 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Kocarek and N. A. Mercer-Haines Squalestatin 1-Inducible Expression of Rat CYP2B: Evidence That an Endogenous Isoprenoid Is an Activator of the Constitutive Androstane Receptor Mol. Pharmacol., November 1, 2002; 62(5): 1177 - 1186. [Abstract] [Full Text] [PDF] |
||||